Logo image of BMEZ

BLACKROCK HLTH SCI TRM TR II (BMEZ) Stock Price, Forecast & Analysis

USA - New York Stock Exchange - NYSE:BMEZ - US09260E1055

15.21 USD
-0.2 (-1.3%)
Last: 12/9/2025, 8:04:00 PM
15.2 USD
-0.01 (-0.07%)
After Hours: 12/9/2025, 8:04:00 PM
Fundamental Rating

3

Taking everything into account, BMEZ scores 3 out of 10 in our fundamental rating. BMEZ was compared to 0 industry peers in the Unkown industry. While BMEZ seems to be doing ok healthwise, there are quite some concerns on its profitability. BMEZ is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year BMEZ has reported negative net income.
In the past year BMEZ had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: BMEZ reported negative net income in multiple years.
Of the past 5 years BMEZ 4 years had a positive operating cash flow.
BMEZ Yearly Net Income VS EBIT VS OCF VS FCFBMEZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 1B -1B -2B

1.2 Ratios

Industry RankSector Rank
ROA -7.06%
ROE -7.2%
ROIC 0.61%
ROA(3y)-9.24%
ROA(5y)-0.06%
ROE(3y)-9.36%
ROE(5y)0.02%
ROIC(3y)N/A
ROIC(5y)N/A
BMEZ Yearly ROA, ROE, ROICBMEZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 20 -20

1.3 Margins

Industry RankSector Rank
OM 25.26%
PM (TTM) N/A
GM 31.02%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BMEZ Yearly Profit, Operating, Gross MarginsBMEZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 5K -5K 10K 15K

More info and screens

5

2. Health

2.1 Basic Checks

BMEZ has less shares outstanding than it did 1 year ago.
There is no outstanding debt for BMEZ. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BMEZ Yearly Shares OutstandingBMEZ Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
BMEZ Yearly Total Debt VS Total AssetsBMEZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

An Altman-Z score of 30.21 indicates that BMEZ is not in any danger for bankruptcy at the moment.
There is no outstanding debt for BMEZ. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 30.21
ROIC/WACCN/A
WACCN/A
BMEZ Yearly LT Debt VS Equity VS FCFBMEZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 1B -1B 2B -2B 3B

2.3 Liquidity

A Current Ratio of 0.49 indicates that BMEZ may have some problems paying its short term obligations.
A Quick Ratio of 0.49 indicates that BMEZ may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.49
Quick Ratio 0.49
BMEZ Yearly Current Assets VS Current LiabilitesBMEZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

3

3. Growth

3.1 Past

BMEZ shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -381.82%.
The Revenue has grown by 105.66% in the past year. This is a very strong growth!
The Revenue has been growing by 66.80% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-381.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-457.14%
Revenue 1Y (TTM)105.66%
Revenue growth 3Y66.8%
Revenue growth 5YN/A
Sales Q2Q%-18.43%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BMEZ Yearly Revenue VS EstimatesBMEZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

BMEZ reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BMEZ Price Earnings VS Forward Price EarningsBMEZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 1.13
EV/EBITDA N/A
BMEZ Per share dataBMEZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

3

5. Dividend

5.1 Amount

BMEZ has a Yearly Dividend Yield of 12.50%, which is a nice return.
Compared to an average S&P500 Dividend Yield of 2.31, BMEZ pays a better dividend.
Industry RankSector Rank
Dividend Yield 12.5%

5.2 History

BMEZ has been paying a dividend for over 5 years, so it has already some track record.
BMEZ has decreased its dividend recently.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
BMEZ Yearly Dividends per shareBMEZ Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

BMEZ has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-295.65%
EPS Next 2YN/A
EPS Next 3YN/A
BMEZ Yearly Income VS Free CF VS DividendBMEZ Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 0 1B -1B -2B

More info and screens

BLACKROCK HLTH SCI TRM TR II

NYSE:BMEZ (12/9/2025, 8:04:00 PM)

After market: 15.2 -0.01 (-0.07%)

15.21

-0.2 (-1.3%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)09-04 2025-09-04
Earnings (Next)03-02 2026-03-02
Inst Owners17.62%
Inst Owner Change2.77%
Ins OwnersN/A
Ins Owner Change0%
Market Cap950.63M
Revenue(TTM)29.69M
Net Income(TTM)-69.00M
Analysts0
Price TargetN/A
Short Float %0.24%
Short Ratio0.56
Dividend
Industry RankSector Rank
Dividend Yield 12.5%
Yearly Dividend1.71
Dividend Growth(5Y)N/A
DP-295.65%
Div Incr Years1
Div Non Decr Years1
Ex-Date11-14 2025-11-14 (0.11)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 32.02
P/FCF 1.13
P/OCF 1.13
P/B 0.99
P/tB 0.99
EV/EBITDA N/A
EPS(TTM)-1.06
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)13.5
FCFY88.78%
OCF(TTM)13.5
OCFY88.78%
SpS0.48
BVpS15.33
TBVpS15.33
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -7.06%
ROE -7.2%
ROCE 0.77%
ROIC 0.61%
ROICexc 0.61%
ROICexgc 0.61%
OM 25.26%
PM (TTM) N/A
GM 31.02%
FCFM 2842.71%
ROA(3y)-9.24%
ROA(5y)-0.06%
ROE(3y)-9.36%
ROE(5y)0.02%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.49
Quick Ratio 0.49
Altman-Z 30.21
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-381.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-457.14%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)105.66%
Revenue growth 3Y66.8%
Revenue growth 5YN/A
Sales Q2Q%-18.43%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y162.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y231.11%
FCF growth 3Y12.07%
FCF growth 5YN/A
OCF growth 1Y231.11%
OCF growth 3Y12.07%
OCF growth 5YN/A

BLACKROCK HLTH SCI TRM TR II / BMEZ FAQ

What does BLACKROCK HLTH SCI TRM TR II do?

BlackRock Health Sciences Term Trust is a US-based company operating in industry. The company is headquartered in Wilmington, Delaware. The company went IPO on 2020-01-29. BlackRock Health Sciences Term Trust (the Trust) is a closed-end management investment trust. The Trust’s investment objectives are to provide total return and income through a combination of current income, current gains, and long-term capital appreciation. The Trust invests at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries. Trust may also invest in companies of any market capitalization located anywhere in the world, including companies located in emerging markets. The Trust focuses on small and mid-sized healthcare companies. The Trust invests in industries, such as biotechnology, life sciences tools and services, pharmaceuticals, financial services, health care technology, hotels, restaurants and leisure, and others. The Trust’s investment adviser is BlackRock Advisors, LLC.


Can you provide the latest stock price for BLACKROCK HLTH SCI TRM TR II?

The current stock price of BMEZ is 15.21 USD. The price decreased by -1.3% in the last trading session.


What is the ChartMill technical and fundamental rating of BMEZ stock?

BMEZ has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 3 out of 10.